Akums Drugs Q2 Results: Profit nearly triples, EBITDA doubles on strong CDMO growth
Akums Drugs reported a 177% jump in Q2 net profit, with revenue rising 32%. Strong CDMO growth and improved operating margins supported the pharmaceutical manufacturer's performance.